Previous 10 | Next 10 |
Shares of Phio Pharmaceuticals Corp. (NASDAQ:PHIO) traded today at $1.72, breaking its 52-week low. This new low was reached on below average trading volume as 166,000 shares traded hands, while the average 30-day volume is approximately 417,000 shares. Potential upside of 65.3% exists f...
Phio Pharmaceuticals Scheduled to Participate in a Fireside Chat with H.C. Wainwright on July 12th PR Newswire MARLBOROUGH, Mass. , July 7, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of i...
Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th PR Newswire MARLBOROUGH, Mass. , June 22, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-...
Phio Pharmaceuticals Scheduled to Participate in Two Upcoming Investor Events in June PR Newswire MARLBOROUGH, Mass. , June 14, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-o...
Phio Pharmaceuticals Presents New In Vivo Data at the 2021 ASCO Annual Meeting Showing Dual-Targeting INTASYL Offers Increased Efficacy and Safety Potential Over Other Therapeutic Approaches Treatment with INTASYL dual-targeting BRD4 and PD-1, elicits complete tumor responses an...
Phio Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update PR Newswire MARLBOROUGH, Mass. , May 13, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of ...
Phio Pharmaceuticals (PHIO) announces positive new in vivo data showing that PH-762 significantly enhanced the antitumor efficacy of HER2-targeted CAR-T cells (HER2CART) in solid tumors.A statistically significant and durable inhibition of tumor growth was seen in PH-762-treated HER2CART cell...
Intec Pharma (NTEC) +25%.Ferro Corporation (FOE) +23% on Q1 results.Cerecor (CERC) +15% as FDA grants fast track designation to its CERC-002.FutureFuel Corp. (FF) +14% on special dividend.Larimar Therapeutics (LRMR) +13% on Q1 results.Advanced Emissions Solutions (ADES) +1...
Phio Pharmaceuticals Presents Positive In Vivo Data at ASGCT Showing PH-762 Significantly Enhanced Antitumor Efficacy of HER2-Targeted CAR-T Cells Data provide proof-of-concept for the application of INTASYL compounds as a way to unlock the potential of CAR-T cell therapy in sol...
Why These Reddit Penny Stocks Could Be Worth Watching Investors looking to make sizable gains in a short time frame often turn to penny stocks. These low-cost stocks have the potential to generate a large profit in a short time frame due to the inherent high volatility. For the same...
News, Short Squeeze, Breakout and More Instantly...
Phio Pharmaceuticals Corp. Company Name:
PHIO Stock Symbol:
NASDAQ Market:
Phio Pharmaceuticals Corp. Website:
Marlborough, Massachusetts--(Newsfile Corp. - July 12, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) (the "Company"), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells...
Five sites across the U.S. are now participating in the Phase 1b study Marlborough, Massachusetts--(Newsfile Corp. - July 8, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to ...
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced i...